KCNJ15 and bladder transitional cell carcinoma: Mutation analysis in TCGA-BLCA samples revealed that 3%, 2.4%, 6%, 3%, and 2.2% of patients had mutations in TM4SF1, KCNK5, FASN, KCNJ15, and IMPDH1, respectively (Figure S4A).